Missing/wrong data?
Log in to edit
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
scientific article
Author/s
author: Javier Cortes, Fabio Puglisi, Christelle Levy, Xavier Pivot, Carlo Putzu
Work details
Publication date
August 8, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.